AAAAAA

   
Results: 1-13 |
Results: 13
Clinical markers of early disease in persons near onset of Huntington's disease
Authors: Paulsen, JS Zhao, H Stout, JC Brinkman, RR Guttman, M Ross, CA Como, P Manning, C Hayden, MR Shoulson, I
Citation: Js. Paulsen et al., Clinical markers of early disease in persons near onset of Huntington's disease, NEUROLOGY, 57(4), 2001, pp. 658-662
A randomized, placebo-controlled trial of coenzyme Q(10) and remacemide inHuntington's disease
Authors: Kieburtz, K Koroshetz, W McDermott, M Beal, MF Greenamyre, JT Ross, CA Shoulson, I Cudkowicz, ME Sexton, P Skeuse, C Rosas, D Jenkins, B Rosenblatt, A Sherr, M Hersch, S Cellar, J Guttman, M Brown, C Como, PG Marshall, F DeMarcaida, JA Zimmerman, C Marder, K Moskowitz, C Polanco, C Beltre, J Shannon, K Jaglin, JA Niederman, F Ashizawa, T Hunter, C Hunter, C Hauser, R Walker, A Gauger, L Hahn, MA Delgado, H Dawson, T Siemers, E Seeberger, L Dingmann, C Dubinsky, R Gray, C Weiner, WJ Rodriguez-Batemen, D Albin, RL Wernette, K Harrison, M Rost-Ruffner, E Paulsen, J Rodnitzky, RL Dobson, J Vining, L Suchowersky, O Pantella, C Saint-Hilaire, MH Furtado, J Martin, W Wieler, M Walker, F Hunt, V Raymond, L Almqvist, E Rubin, A Blair, B Marek, K Caplan, K Baker, D Brocht, A Casaceli, C Orme, C Rudolph, A Rumfola, L Schifitto, G Shinaman, A Sulimowicz, K Watts, A Eapen, S Zhang, L
Citation: K. Kieburtz et al., A randomized, placebo-controlled trial of coenzyme Q(10) and remacemide inHuntington's disease, NEUROLOGY, 57(3), 2001, pp. 397-404
A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease
Authors: Shoulson, I Penney, J McDermott, M Kieburtz, K Schwid, SR Kayson, E Chase, T Fahn, S Greenamyre, JT Lang, A Siderowf, A Pearson, N Harrison, M Rost-Ruffner, E Colcher, A Lloyd, M Matthews, M Pahwa, R McGuire, D Lew, MF Schuman, S Marek, K Broshjeit, S Factor, S Brown, D Feigin, A Mazurkiewicz, J Ford, B Jennings, D Dillon, S Comella, C Blasucci, L Janko, K Shulman, L Wiener, W Bateman-Rodriguez, D Carrion, A Suchowersky, O Lafontaine, AL Pantella, C Siemers, E Belden, J Davies, R Lannon, M Grimes, D Gray, P Martin, W Kennedy, L Adler, C Newman, S Hammerstad, J Stone, C Lewitt, P Bardram, K Mistura, K Miyasaki, J Johnston, L Cha, JHJ Tennis, M Panisset, M Hall, J Tetrud, J Friedlander, J Hauser, R Gauger, L Rodnitzky, R Deleo, A Dobson, J Seeberger, L Dingmann, C Tarsy, D Ryan, P Elmer, L Ruzicka, D Stacy, M Brewer, M Locke, B Baker, D Casaceli, C Day, D Florack, M Hodgeman, K Laroia, N Nobel, R Orme, C Rexo, L Rothenburgh, K Sulimowicz, K Watts, A Wratni, E Tariot, P Cox, C Leventhal, C Alderfer, V Craun, AM Frey, J McCree, L McDermott, J Cooper, J Holdich, T Read, B
Citation: I. Shoulson et al., A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease, NEUROLOGY, 56(4), 2001, pp. 455-462
Evaluation of dyskinesias in a pilot, randomized, placebo-controlled trialof remacemide in advanced Parkinson disease
Authors: Shoulson, I Lang, A Fahn, S McDermott, M Kieburtz, K Schwid, S Kayson, E Chase, T Greenamyre, T Penney, J Frucht, S Winfield, H Goetz, C Blasucci, L Nutt, J Carter, J Morehouse, S Rajput, A Ewanishin, M Johnston, L Casaceli, C Day, D Hodgeman, K Laroia, N de Marcaida, JA Orme, C Watts, A Natarajan, R Huang, P Tariot, P Cox, C Leventhal, C
Citation: I. Shoulson et al., Evaluation of dyskinesias in a pilot, randomized, placebo-controlled trialof remacemide in advanced Parkinson disease, ARCH NEUROL, 58(10), 2001, pp. 1660-1668
A randomized controlled trial comparing pramipexole with levodopa in earlyParkinson's disease: Design and methods of the CALM-PD study
Authors: Holloway, R Shoulson, I Fahn, S Kieburtz, K Lang, A Marek, K McDermott, M Seibyl, J Weiner, W Welsh, M Kamp, C Day, D Pahwa, R Smith, D McGuire, D Barclay, L Sutherland, L Hildebrand, K Hubble, J Weeks, C LeWitt, P Mistura, K Bloomfield, W Miyasaki, J Duff, J Sime, E Suchowersky, O Argatoff, P Andreas, Y Kurth, M Brewer, M Russell, D Fussell, B Ford, B Dillon, S Hammerstad, J Stone, C Riley, D Rainey, P Standaert, D Tennis, M Wooten, F Rost-Ruffner, E Factor, S Brown, D Jankovic, J Beach, J Kurlan, R Gardiner, I Panisset, M Amyot, D Hall, J Rajout, A Wilson, W McCullan, L Brown, K Clark, R Rodnitzky, R Dobson, J Shults, C Fontaine, D Waters, C Welsh, M Pfeiffer, R Rast, S Bujak, G Casaceli, C Freimuth, A Hodgeman, K Honsinger, K Watts, A Hall, WJ Leventhal, CM Reich, S Tariot, P Balgoyen, D Corak, D Corrigan, M Driver, M Fraser, TJ Lai, PY Gomez-Mancilla, B Munting, J Peters, G Rowland, C Sullivan, H Trasky, R Wright, G Berber, E Morris, J Mills, D Hallak, L Rines, S
Citation: R. Holloway et al., A randomized controlled trial comparing pramipexole with levodopa in earlyParkinson's disease: Design and methods of the CALM-PD study, CLIN NEUROP, 23(1), 2000, pp. 34-44
Pramipexole vs levodopa as initial treatment for Parkinson disease - A randomized controlled trial
Authors: Holloway, R Shoulson, I Kieburtz, K McDermott, M Tariot, P Kamp, C Day, D Shinaman, A Fahn, S Lang, A Marek, K Seibyl, J Weiner, W Welsh, M Pahwa, R Coe, S Barclay, L Sutherland, L Hildebrand, K Hubble, J Weeks, C LeWitt, P Miyasaki, J Duff, J Sime, E Suchowersky, O Stacy, M Kurth, M Brewer, M Harrigan, M Russell, DS Fussell, B Ford, B Dillon, S Hammerstad, J Stone, C Riley, D Rainey, P Standaert, D Tennis, M Wooten, F Rost-Ruffner, E Factor, S Brown, D Jankovic, J Atassi, F Kurlan, R Gardiner, I Panisset, M Amyot, D Hall, J Rajput, A Shirley, T Rodnitzky, R Dobson, J Shults, C Fontaine, D Waters, C Welsh, M Schuman, S Pfeiffer, R Rast, S Pfeiffer, B Brocht, A Casaceli, C Daigneault, S Hodgeman, K Honsinger, K O'Connell, C Watts, A
Citation: R. Holloway et al., Pramipexole vs levodopa as initial treatment for Parkinson disease - A randomized controlled trial, J AM MED A, 284(15), 2000, pp. 1931-1938
A multicenter randomized controlled trial of remacemide hydrochloride as monotherapy for PD
Authors: Shoulson, I Greenamyre, T Kieburtz, K Schwid, S McDermott, M Kayson, E Chase, T Fahn, S Lang, A Penney, J Hauser, R Gauger, L Kumar, R Keable, L Sime, E Siemers, E Belden, J Pappert, EJ Janko, K Trugman, JM Rost-Ruffner, E Kurlan, R Pearson, N Carter, J Nutt, J Stone, C Perlmutter, JS McGee-Minnich, L Freeman, A Duddleston, C Stacy, M Brewer, M Locke, B Stern, M Matthews, M Friedman, J Davies, R Lannon, M Grimes, D Gray, P Shults, C Fontaine, D O'Brien, C Dingmann, C Feigin, A Mazurkiewicz, J Elmer, L Wernette, K Singer, C Bateman-Rodriguez, D Carrion, A Fernandez, M Pfeiffer, R Pfeiffer, B Rast, S Pahwa, R McGuire, D Brin, M Walker, R Casaceli, C Day, D Hodgeman, K Huang, P Orme, C Sulimowicz, K Watts, A Means, E Alderfer, V Letizia, J Craun, AM Cooper, J Holdich, T Read, B
Citation: I. Shoulson et al., A multicenter randomized controlled trial of remacemide hydrochloride as monotherapy for PD, NEUROLOGY, 54(8), 2000, pp. 1583-1588
Rate of functional decline in Huntington's disease
Authors: Marder, K Zhao, H Myers, RH Cudkowicz, M Kayson, E Kieburtz, K Orme, C Paulsen, J Penney, JB Siemers, E Shoulson, I
Citation: K. Marder et al., Rate of functional decline in Huntington's disease, NEUROLOGY, 54(2), 2000, pp. 452-458
Jack Penney - In memoriam
Authors: Shoulson, I
Citation: I. Shoulson, Jack Penney - In memoriam, MOVEMENT D, 14(3), 1999, pp. 393-394
Mortality in DATATOP - Reply
Authors: Shoulson, I Oakes, D Olanow, CW
Citation: I. Shoulson et al., Mortality in DATATOP - Reply, ANN NEUROL, 45(1), 1999, pp. 139-139
The impact of remacemide hydrochloride on levodopa concentrations in Parkinson's disease
Authors: Schwid, SR Kieburtz, K Nutt, J McDermott, M Kayson, E Chase, T Fahn, S Greenamyre, T Lang, A Penney, J Shoulson, I
Citation: Sr. Schwid et al., The impact of remacemide hydrochloride on levodopa concentrations in Parkinson's disease, CLIN NEUROP, 22(4), 1999, pp. 220-225
Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children
Authors: Swanson, J Gupta, S Guinta, D Flynn, D Agler, D Lerner, M Williams, L Shoulson, I Wigal, S
Citation: J. Swanson et al., Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children, CLIN PHARM, 66(3), 1999, pp. 295-305
Neurotherapeutics, evidence-based neurology, and clinical equipoise
Authors: Shoulson, I Rosenberg, RN
Citation: I. Shoulson et Rn. Rosenberg, Neurotherapeutics, evidence-based neurology, and clinical equipoise, ARCH NEUROL, 56(5), 1999, pp. 524-524
Risultati: 1-13 |